Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kam Wa Chan

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Chinese Medicine|January 25, 2022
Chinese herbal medicine treatment based on subgroup differentiation as adjunct therapy for Parkinson's disease: study protocol of a pilot add-on, randomised, controlled, pragmatic clinical trialSam Chun Sum Yuen, Ka Kit Chua, Linda L D Zhong, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 4, 2020
Direct Renin Inhibition in Non-diabetic chronic Kidney disease (DRINK): a prospective randomized trialSydney C W Tang, Kam Wa Chan, Dennis K M Ip, et al.
Frontiers in Pharmacology|April 17, 2026
Can <i>Patrinia villosa</i> water extract be taken during FOLFOX treatment in colon cancer? - evidences from a proof-of-concept preclinical studyGrace Gar-Lee Yue, Kit-Man Lau, Dandan Hu, et al.
Frontiers in Endocrinology|December 11, 2024
Association of systemic immune-inflammation index with all-cause and cardio-cerebrovascular mortality in individuals with diabetic kidney disease: evidence from NHANES 1999-2018Manhuai Zhang, Siyang Ye, Jianbo Li, et al.
Clinical Science (London, England : 1979)|October 20, 2020
The PAR-1 antagonist vorapaxar ameliorates kidney injury and tubulointerstitial fibrosisSarah W Y Lok, Wai Han Yiu, Hongyu Li, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|November 7, 2025
Urinary Albumin-to-Creatinine Ratio, Cardiovascular Health, and All-Cause Mortality in Hypertension: A Nationwide Cohort AnalysisDingding Wang, Meng Zhang, Peichen Xie, et al.
Kidney International|September 1, 2023
Post hoc analysis of the SONAR trial indicates that the endothelin receptor antagonist atrasentan is associated with less pain in patients with type 2 diabetes and chronic kidney diseaseKam Wa Chan, J David Smeijer, Meir Schechter, et al.
Stem Cells Translational Medicine|May 5, 2019
Amelioration of Endoplasmic Reticulum Stress by Mesenchymal Stem Cells via Hepatocyte Growth Factor/c-Met Signaling in Obesity-Associated Kidney InjuryBin Li, Joseph C K Leung, Loretta Y Y Chan, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 3, 2018
Complement C5a inhibition moderates lipid metabolism and reduces tubulointerstitial fibrosis in diabetic nephropathyWai Han Yiu, Rui Xi Li, Dickson W L Wong, et al.
Kidney International|April 2, 2018
Activated renal tubular Wnt/β-catenin signaling triggers renal inflammation during overload proteinuriaDickson W L Wong, Wai Han Yiu, Kam Wa Chan, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Chinese Medicine|January 25, 2022
Chinese herbal medicine treatment based on subgroup differentiation as adjunct therapy for Parkinson's disease: study protocol of a pilot add-on, randomised, controlled, pragmatic clinical trialSam Chun Sum Yuen, Ka Kit Chua, Linda L D Zhong, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 4, 2020
Direct Renin Inhibition in Non-diabetic chronic Kidney disease (DRINK): a prospective randomized trialSydney C W Tang, Kam Wa Chan, Dennis K M Ip, et al.
Frontiers in Pharmacology|April 17, 2026
Can <i>Patrinia villosa</i> water extract be taken during FOLFOX treatment in colon cancer? - evidences from a proof-of-concept preclinical studyGrace Gar-Lee Yue, Kit-Man Lau, Dandan Hu, et al.
Frontiers in Endocrinology|December 11, 2024
Association of systemic immune-inflammation index with all-cause and cardio-cerebrovascular mortality in individuals with diabetic kidney disease: evidence from NHANES 1999-2018Manhuai Zhang, Siyang Ye, Jianbo Li, et al.
Clinical Science (London, England : 1979)|October 20, 2020
The PAR-1 antagonist vorapaxar ameliorates kidney injury and tubulointerstitial fibrosisSarah W Y Lok, Wai Han Yiu, Hongyu Li, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|November 7, 2025
Urinary Albumin-to-Creatinine Ratio, Cardiovascular Health, and All-Cause Mortality in Hypertension: A Nationwide Cohort AnalysisDingding Wang, Meng Zhang, Peichen Xie, et al.
Kidney International|September 1, 2023
Post hoc analysis of the SONAR trial indicates that the endothelin receptor antagonist atrasentan is associated with less pain in patients with type 2 diabetes and chronic kidney diseaseKam Wa Chan, J David Smeijer, Meir Schechter, et al.
Stem Cells Translational Medicine|May 5, 2019
Amelioration of Endoplasmic Reticulum Stress by Mesenchymal Stem Cells via Hepatocyte Growth Factor/c-Met Signaling in Obesity-Associated Kidney InjuryBin Li, Joseph C K Leung, Loretta Y Y Chan, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 3, 2018
Complement C5a inhibition moderates lipid metabolism and reduces tubulointerstitial fibrosis in diabetic nephropathyWai Han Yiu, Rui Xi Li, Dickson W L Wong, et al.
Kidney International|April 2, 2018
Activated renal tubular Wnt/β-catenin signaling triggers renal inflammation during overload proteinuriaDickson W L Wong, Wai Han Yiu, Kam Wa Chan, et al.
Pageof 5